Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Shared decision-making for multiple sclerosis using the MS-SUPPORT tool: a plain language summary.
Journal: Neurodegenerative disease management
Published: May 07, 2025
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Journal: The New England journal of medicine
Published: April 09, 2025
Paramagnetic rim lesions are highly specific for multiple sclerosis in real-world data.
Journal: Brain communications
Published: November 18, 2024
Paramagnetic Rim Lesions are Highly Specific for Multiple Sclerosis in Real-World Data.
Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2024
Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes.
Journal: Scientific reports
Published: April 21, 2024
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
Journal: Neurology. Clinical practice
Published: April 03, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.
Journal: JAMA neurology
Published: March 11, 2024
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
Journal: Brain : a journal of neurology
Published: September 21, 2023
Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
Journal: Multiple sclerosis and related disorders
Published: June 21, 2023
Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 20, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2023
Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results.
Journal: Multiple sclerosis and related disorders
Published: December 21, 2022
Last Updated: 09/26/2026